ULK3 and familial pancreatic carcinoma: Similar results were observed in the Treatment scenarios by inhibiting SMO, HFU, ULK3 and RAS in Colon cancer cell line and SMO, HFU, ULK3, RAS and ERK12 in Pancreatic cancer cell lines (See the second columns of Figure 8B and C).